Utilization of Drug Information Systems by Medical Representatives in the Japanese Pharmaceutical Industry
- PDF / 551,386 Bytes
- 7 Pages / 504 x 719.759 pts Page_size
- 43 Downloads / 167 Views
Drug Information J o u m l , Vol. 32. pp. 761-767, 1998 Printed in the USA. All rights reserved.
Copyright 0 1998 Drug Information Association Inc.
UTILIZATION OF DRUG INFORMATION SYSTEMS BY MEDICAL REPRESENTATIVES IN THE JAPANESE PHARMACEUTICAL INDUSTRY MANAIYAMAMOTO, TOMOKO IIZUKA, HISAKONEGI,MAYUMISHIMIZU, SHOICHI
FUNABASHI, AND
SEIZAsURO OKADA,
PHD
PMS Administration Department, Daiichi Pharmaceutical Co., Ltd., Tokyo, Japan
Forfull utilization of a drug information database system by users, education and support activities are indispensable. Daiichi Pharmaceutical Co., Ltd. ’s PMS Administration Department h a s facilitated familiarization of users with its in-house database systems and improved their utilization through an in-house training campaign, analysis of information retrieved (logfiles),feedback on the results, on-screen information services on the updated databases, contributions to in-house publications, and so forth. Through these activities to facilitate familiarization with and utilization of the database, medical representatives (MRs) accessing databases increased from 44% to 80% over four years. This report presents activities to improve the utilization of Daiichi Pharmaceutical’s databases by MRs and some examples. Key Words: Drug information; Medical representatives; Pharmaceutical industry; Educational training system
INTRODUCTION DRUG INFORMATION (DI) SERVICES are a fundamental operation in the pharmaceutical industry. Various in-house databases have been built at each company for the purpose of aiding DI services. Users, however, are often unfamiliar with available information and ask for information which has already been stored in the database. Daiichi Pharmaceutical’s PMS Administration Department has always felt that in-house training and support activities are important to Reprint address: Manai Yamamoto, PMS Administration Department, Daiichi Pharmaceutical Co., Ltd., 16-1, Kyobashi Z-Chome, Chuo-ku, Tokyo, 104-8369 Japan.
improve utilization of databases. While many publications about building databases are available (l-fj), there are only a few publications where improvement of utilization of inhouse databases is discussed. In Japan, the qualifications of medical representatives (MRs) who primarily shoulder the DI services in the medical field are specified in the “Guidelines for information services of MRs.” Furthermore, a qualifying examination system for MRs will be introduced in December 1997 (7,8,9). Therefore, the medical knowledge of MRs must be expanded, and they must be provided with more relevant scientific data, including the published literature, through active use of database systems. This report discusses Daiichi Pharmaceutical’s current training system and
761
Downloaded from dij.sagepub.com at University of Manitoba Libraries on June 22, 2015
762
M . Yamamoto et al.
support activities to facilitate utilization of its databases by users including MRs, and the results of these improvement activities.
METHODS (CURRENT ACTIVITIES TO IMPROVE UTILIZATION O
Data Loading...
